Sepracor, Inc. Announces Presentation Of LUNESTA(TM) Data At Associated Professional Sleep Societies 20th Anniversary Meeting

MARLBOROUGH, Mass.--(BUSINESS WIRE)--June 23, 2006--Sepracor Inc. (Nasdaq: SEPR - News) today announced that additional data on LUNESTA(TM) brand eszopiclone for the treatment of insomnia were presented at the SLEEP 2006 20th Anniversary Meeting of the Associated Professional Sleep Societies in Salt Lake City. The data included four oral presentations of results from LUNESTA Phase IIIB/IV study data.

Back to news